Show simple item record

Patient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed study

dc.contributor.authorMandizha, J
dc.contributor.authorLanario, JW
dc.contributor.authorDuckworth, A
dc.contributor.authorLines, S
dc.contributor.authorPaiva, A
dc.contributor.authorElworthy, V
dc.contributor.authorMuraleedharan, V
dc.contributor.authorDa Ponte, AJ
dc.contributor.authorShuttleworth, R
dc.contributor.authorBrown, G
dc.contributor.authorAlmond, H
dc.contributor.authorBond, C
dc.contributor.authorCosby, M
dc.contributor.authorDallas, J
dc.contributor.authorNaqvi, M
dc.contributor.authorRussell, AD
dc.contributor.authorBerry, A
dc.contributor.authorGibbons, M
dc.contributor.authorScotton, CJ
dc.contributor.authorRussell, A-M
dc.date.accessioned2024-01-26T10:48:35Z
dc.date.issued2023-10-03
dc.date.updated2024-01-26T09:03:06Z
dc.description.abstractBACKGROUND: Opportunities for home-monitoring are increasing exponentially. Home- spirometry is reproducible and reliable in interstitial lung disease (ILD), yet patients' experiences are not reported. Given the morbidity and mortality associated with ILDs, maintaining health-related quality-of-life is vital. We report our findings from a codesigned, qualitative study capturing the perspectives and experiences of patients using home-spirometry in a UK regional ILD National Health Service England (NHSE) commissioned service. METHODS: Patients eligible for home-spirometry as routine clinical care, able to give consent and able to access a smart phone were invited to participate. In-depth, semistructured interviews were conducted at serial time points (baseline, 1, 3 and 6 months), recorded, transcribed and analysed thematically. RESULTS: We report on the experiences of 10 recruited patients (8 males; median age 66 years, range 50-82 years; 7 diagnosed with idiopathic pulmonary fibrosis, 3 other ILDs) who generally found spirometry convenient and easy to use, but their relationships with forced vital capacity results were complex. Main themes emerging were: (1) anticipated benefits-to identify change, trigger action and aid understanding of condition; (2) needs-clinical oversight and feedback, understanding of results, ownership, need for data and a need 'to know'; (3) emotional impact-worry, reassurance, ambivalence/conflicting feelings, reminder of health issues, indifference; (4) ease of home-spirometry-simplicity, convenience and (5) difficulties with home-spirometry-technical issues, technique, physical effort. CONCLUSION: Home-spirometry has many benefits, but in view of the potential risks to psychological well-being, must be considered on an individual basis. Informed consent and decision-making are essential and should be ongoing, acknowledging potential limitations as well as benefits. Healthcare support is vital.en_GB
dc.description.sponsorshipNational Institute for Health and Care Research (NIHR)en_GB
dc.identifier.citationVol. 10, No.1, article e001837en_GB
dc.identifier.doihttps://doi.org/10.1136/bmjresp-2023-001837
dc.identifier.grantnumberJM22-23en_GB
dc.identifier.urihttp://hdl.handle.net/10871/135144
dc.identifierORCID: 0000-0002-9671-9057 (Scotton, Christopher J)
dc.identifierORCID: 0000-0002-0468-3537 (Russell, Anne-Marie)
dc.language.isoenen_GB
dc.publisherBMJ Publishingen_GB
dc.relation.urlhttps://www.ncbi.nlm.nih.gov/pubmed/37793682en_GB
dc.rights© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/en_GB
dc.subjectinterstitial fibrosisen_GB
dc.subjectpatient outcome assessmenten_GB
dc.subjectrespiratory function testen_GB
dc.titlePatient perspectives on home-spirometry in interstitial lung disease: a qualitative co-designed studyen_GB
dc.typeArticleen_GB
dc.date.available2024-01-26T10:48:35Z
dc.identifier.issn2052-4439
exeter.article-numbere001837
exeter.place-of-publicationEngland
dc.descriptionThis is the final version. Available on open access from BMJ Publishing via the DOI in this record. en_GB
dc.descriptionData availability statement: Data are available upon reasonable request. Deidentified participant data, thematic analysis and coding system will be made available in response to reasonable request made to the corresponding author. We will seek approval from our governance team and patient research partners advisory board.en_GB
dc.identifier.journalBMJ Open Respiratory Researchen_GB
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/en_GB
dcterms.dateAccepted2023-09-01
dcterms.dateSubmitted2023-05-18
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2023-10-03
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2024-01-26T09:03:10Z
refterms.versionFCDVoR
refterms.dateFOA2024-01-26T10:48:36Z
refterms.panelAen_GB
refterms.dateFirstOnline2023-10-03


Files in this item

Name:
Patient perspectives on home-s ...
Size:
409.8Kb
Format:
PDF
Description:
Patient perspectives on home-s ...
View/Open

This item appears in the following Collection(s)

Show simple item record

© Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/
Except where otherwise noted, this item's licence is described as © Author(s) (or their employer(s)) 2023. Re-use permitted under CC BY. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 Unported (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/